首页> Transplantation and cellular therapy> Impact of Novel Targeted Therapies and Cytogenetic Risk Groups on Outcome After Allogeneic Transplantation for Adult ALL.

Impact of Novel Targeted Therapies and Cytogenetic Risk Groups on Outcome After Allogeneic Transplantation for Adult ALL.

导出 LinkOut

翻译打印收藏纠错

第一作者： Zaid H,Abdel Rahman

第一单位： Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida.

作者： Zaid H,Abdel Rahman ^[1] ; Michael G,Heckman ^[2] ; Kevin,Miller ^[3] ; Hassan,Alkhateeb ^[4] ; Mrinal S,Patnaik ^[4] ; Lisa Z,Sproat ^[5] ; Liuyan,Jiang ^[6] ; Vivek,Roy ^[1] ; Hemant S,Murthy ^[1] ; Ernesto,Ayala ^[1] ; William J,Hogan ^[4] ; Patricia T,Greipp ^[7] ; Mohamed A,Kharfan-Dabaja ^[1] ; Mark R,Litzow ^[4] ; James M,Foran ^[8]

作者单位： Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida. ^[1] Division of Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville, Florida. ^[2] Department of Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts. ^[3] Division of Hematology, Mayo Clinic, Rochester, Minnesota. ^[4] Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, Arizona. ^[5] Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, Florida. ^[6] Department of Clinical Genomics, Mayo Clinic, Rochester, Minnesota. ^[7] Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida. Electronic address: Foran.James@mayo.edu. ^[8]

关键词 Acute lymphoblastic leukemia Allo-HCT Allogeneic transplantation Blinatumomab Hypodiploidy Ph-like

医学主题词成年人(Adult);细胞遗传学分析(Cytogenetic Analysis);移植物抗宿主病(Graft vs Host Disease);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);移植预处理(Transplantation Conditioning);移植, 同种(Transplantation, Homologous)

DOI 10.1016/j.jtct.2020.10.015

PMID 33830026

发布时间 2021-07-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交